David Young - 09 Feb 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
09 Feb 2023
Transactions value $
$15,000
Form type
4
Filing time
10 Feb 2023, 16:04:55 UTC
Previous filing
04 Jan 2023
Next filing
13 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $15,000 +18,750 +5.7% $0.8 350,424 09 Feb 2023 Direct
holding PCSA Common Stock 619,677 09 Feb 2023 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 215,703 09 Feb 2023 By Family Entities
holding PCSA Common Stock 370,887 09 Feb 2023 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.